Journal of Neurochemistry 1986-01-01

Development of the gamma-aminobutyric acid neurotransmitter system in the rat cerebral cortex during repeated administration of the GABA-transaminase inhibitor ethanolamine O-sulphate.

C C Sykes, R W Horton

Index: J. Neurochem. 46(1) , 213-7, (1986)

Full Text: HTML

Abstract

Ethanolamine O-sulphate (400 mg/kg, i.p.) was administered to rat pups at 9 days of age and on alternate days up to 17 days of age. At 18 days of age, gamma-aminobutyric acid (GABA) concentration was increased (three- to fourfold), glutamic acid decarboxylase (GAD) activity reduced to 55% of control, and the number of GABAA and GABAB binding sites increased in the cerebral cortex. This is the same pattern of change as seen previously with oral administration of ethanolamine O-sulphate to the adult rat but the changes occur more rapidly in the developing rat. A lower dose of ethanolamine O-sulphate (100 mg/kg, i.p.), administered according to the same schedule, caused a twofold increase in cortical GABA at 18 days of age whereas GAD activity and GABAA binding were not significantly altered.


Related Compounds

Related Articles:

Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

2006-10-01

[Anal. Bioanal. Chem 386(3) , 666-74, (2006)]

The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.

1995-05-01

[J. Neurochem. 64 , 2256, (1995)]

GABA-mimetic compounds block haloperidol-induced hyperprolactinemia in rats.

1986-01-01

[Adv. Biochem. Psychopharmacol. 42 , 139-44, (1986)]

New urea-based surfactants derived from alpha,omega-amino acids.

2009-01-29

[J. Phys. Chem. B 113(4) , 977-82, (2009)]

Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain.

1990-01-01

[Life Sci. 46(22) , 1587-95, (1990)]

More Articles...